Human immunodeficiency virus risk behavior among female substance abusers.
HIV is an increasingly critical and costly health problem for American women. Substance use plays a major role in human immunodeficiency virus (HIV) infection in women. There are several plausible explanations for the association between substance use and HIV risk behavior. Pregnant substance abusers are a population deserving special attention given the prevalence of risk behavior in this population and the added risk of perinatal transmission of HIV. Current guidelines for the screening and treatment of HIV among pregnant women and their infants are delineated. Substance abuse treatment has a limited impact on HIV risk behavior in female substance abusers. Similarly, traditional knowledge-based and skill-based HIV risk reduction interventions have modest efficacy in this population. Hence, there is a need to develop new interventions that directly target sex-related and drug-related HIV risk behavior among female substance abusers. Recent work suggests that the incorporation of motivational interviewing components into traditional HIV risk reduction interventions may be a promising new direction for the field.
Ramsey
Susan E
SE
The Warren Alpert Medical School of Brown University, Providence, RI, USA. Susan_Ramsey@Brown.edu
Bell
Kathryn M
KM
Engler
Patricia A
PA
D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000453:epidemiology / Q000635:transmission; D015497:HIV-1; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D011247:Pregnancy; D012309:Risk-Taking; D012725:Sexual Behavior; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000453:epidemiology / Q000523:psychology; D019966:Substance-Related Disorders / Q000150:complications* / Q000453:epidemiology / Q000523:psychology; D014481:United States / Q000453:epidemiology
Adv Alcohol Subst Abuse. 1987;7(2):73-88
3448894
Health Psychol. 1994 Sep;13(5):397-403
7805634
Annu Rev Sex Res. 2004;15:258-96
16913281
MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4
12489844
Exp Clin Psychopharmacol. 1999 Feb;7(1):49-55
10036609
J Adolesc Health. 1996 Nov;19(5):331-6
8934293
Drug Alcohol Depend. 2000 Mar 1;58(3):219-26
10759032
J Drug Educ. 1993;23(1):57-66
8487142
J Consult Clin Psychol. 1997 Aug;65(4):531-41
9256553
Am Psychol. 1993 Oct;48(10):1035-45
8256876
J Stud Alcohol Suppl. 1999 Mar;13:130-8
10225497
Addiction. 2001 Dec;96(12):1725-42
11784466
Drug Alcohol Depend. 2000 Apr 1;59(1):17-31
10706972
Psychol Bull. 2002 Nov;128(6):851-885
12405135
Psychol Bull. 1992 May;111(3):455-74
1594721
Am J Health Promot. 1995 Sep-Oct;10(1):27-36
10155656
Obstet Gynecol. 2003 Oct;102(4):782-90
14551009
Drug Alcohol Depend. 2000 Mar 1;58(3):237-45
10759034
Health Psychol. 2000 May;19(3):290-8
10868774
Health Psychol. 2000 Jan;19(1):3-11
10711582
Sex Transm Dis. 2002 Aug;29(8):476-82
12172533
Health Psychol. 1996 Mar;15(2):114-23
8681919
Am Psychol. 1995 Jun;50(6):437-47
7598292
J Subst Abuse Treat. 2000 Dec;19(4):319-28
11166496
J Sex Res. 2003 Feb;40(1):50-60
12806531
AIDS Care. 1996 Dec;8(6):655-69
8993716
J Consult Clin Psychol. 1998 Oct;66(5):856-61
9803706
JAMA. 2001 Mar 7;285(9):1186-92
11231749
J Stud Alcohol. 1999 May;60(3):368-77
10371265
Exp Clin Psychopharmacol. 2004 Nov;12(4):288-97
15571446
J Stud Alcohol Suppl. 2002 Mar;(14):101-17
12022716
AIDS Behav. 1999 Dec;3(4):269-276
18568093
MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4
16988643
Addiction. 1996 Aug;91(8):1115-25
8828240
Fam Plann Perspect. 1997 May-Jun;29(3):132-6
9179583
Fam Plann Perspect. 1991 Nov-Dec;23(6):264-6, 270-1
1786807
Drug Alcohol Depend. 2001 Sep 1;64(1):97-104
11470345
Am J Prev Med. 1998 Jul;15(1):54-9
9651639
Psychol Bull. 1999 Jan;125(1):90-132
9990846
J Consult Clin Psychol. 2003 Oct;71(5):843-61
14516234
Am J Public Health. 1994 Dec;84(12):1918-22
7998630
JAMA. 1995 Oct 25;274(16):1271-6
7563531
N Engl J Med. 1994 Nov 24;331(21):1422-7
7969281
Health Educ Q. 1986 Winter;13(4):359-71
3781860